To amend title 10, United States Code, to provide wigs to TRICARE beneficiaries with alopecia, including alopecia caused by chemotherapy, and for other purposes.
Latest action (1 Oct 2026): Introduced
What this bill does
This bill, H.R. 10717, introduced by Representative Eugene Vindman, proposes to change federal law concerning medical coverage for TRICARE beneficiaries. Specifically, the bill aims to amend Title 10 of the United States Code to ensure that individuals covered by TRICARE who experience hair loss due to alopecia, including hair loss resulting from chemotherapy treatments, would receive wigs.
The primary effect of this legislation, if passed, would be to expand the covered medical benefits under TRICARE to include the provision of wigs for beneficiaries diagnosed with alopecia. This would apply to a range of individuals using the TRICARE health program, particularly those undergoing cancer treatment.
As of now, H.R. 10717 has been introduced in the 119th Congress. Its current status is "Introduced," meaning it has been formally presented to the House of Representatives. The bill has not yet moved to any further legislative stages, and its full text is not yet publicly available.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
This bill is in the first stage of the legislative process. It was introduced into Congress on October 1, 2026. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
Common questions
- What does H.R. 10717 do?
- This bill, H.R. 10717, introduced by Representative Eugene Vindman, proposes to change federal law concerning medical coverage for TRICARE beneficiaries. Specifically, the bill aims to amend Title 10 of the United States Code to ensure that individuals covered by TRICARE who experience hair loss due to alopecia, including hair loss resulting from chemotherapy treatments, would receive wigs. The primary effect of this legislation, if passed, would be to expand the covered medical benefits under TRICARE to include the provision of wigs for beneficiaries diagnosed with alopecia. This would apply to a range of individuals using the TRICARE health program, particularly those undergoing cancer treatment. As of now, H.R. 10717 has been introduced in the 119th Congress. Its current status is "Introduced," meaning it has been formally presented to the House of Representatives. The bill has not yet moved to any further legislative stages, and its full text is not yet publicly available.
- Has H.R. 10717 become law?
- Not yet. As of 1 Oct 2026, H.R. 10717 is introduced.
- Who sponsored H.R. 10717?
- H.R. 10717 was sponsored by Rep. Eugene Vindman [D-VA7] (Democrat-VA), with 0 cosponsors.
- What's the latest action on H.R. 10717?
- Introduced (1 Oct 2026).
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.